Skip to content

Ginger effect on salivary secretion

Evaluate the effect of ginger extract on salivary secretion in patients with radiation-induced xerostomia (double-blind study - controlled)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013120915723N1
Enrollment
40
Registered
2014-04-14
Start date
2012-03-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Xerostomia. Disturbances of salivary secretion

Interventions

Intervention 1: Ginger capsules, 500 mg orally four times daily for two weeks. Intervention 2: Starch capsules, 500 mg orally four times daily for two weeks.
Treatment - Drugs
Placebo
Ginger capsules, 500 mg orally four times daily for two weeks.
Starch capsules, 500 mg orally four times daily for two weeks.

Sponsors

Ahvaz Jundishapur University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria were: 1- Patients had a history of head and neck cancer and its treatment with high-dose radiotherapy of 45 Gy have been.. 2-At least 6 months past the end of radiotherapy patients. 3 - Age above 18 years 4 - confirms xerostomia questionnaire with Fox 5 - to sign a consent form inclusion Criteria excluded : 1 - Pregnancy 2 - Patients with more than 3 months has passed from cancer treatment. 3 - Patients who can not take food by mouth. 4 - Radiation therapy to patients who have not received their full. 5 - Patients with Sjogren's syndrome or other causes of dry mouth (except radiation) are. Exclusion criteria were: 1 - pregnancy during the study 2 - Sensitivity Ginger.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Xerostomia. Timepoint: Beginning of the study, two weeks after baseline (end of study). Method of measurement: Questionnaire.;Weight of unstimulation saliva. Timepoint: Beginning of the study, two weeks after baseline (end of study). Method of measurement: Milligrams.

Secondary

MeasureTime frame
Improved quality of life. Timepoint: Beginning of the study two weeks after baseline (end of study). Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Shooriabi

Ahvaz Jundishapur University of Medical Sciences

dsshoriabii@yahoo.com+98 61 1320 5169

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026